ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102,359 | +21.7% | 7,790 | +16.7% | 0.00% | – |
Q2 2023 | $84,128 | -49.2% | 6,677 | -47.4% | 0.00% | – |
Q1 2023 | $165,520 | +49.2% | 12,684 | +101.6% | 0.00% | – |
Q4 2022 | $110,969 | +4.7% | 6,291 | -9.7% | 0.00% | – |
Q3 2022 | $106,000 | +19.1% | 6,969 | +16.3% | 0.00% | – |
Q2 2022 | $89,000 | -96.8% | 5,993 | -95.2% | 0.00% | – |
Q1 2022 | $2,820,000 | +140900.0% | 125,266 | +106965.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 117 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 117 | -16.4% | 0.00% | – |
Q2 2021 | $3,000 | -80.0% | 140 | -86.1% | 0.00% | – |
Q1 2021 | $15,000 | 0.0% | 1,008 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | +50.0% | 1,008 | -17.0% | 0.00% | – |
Q3 2020 | $10,000 | +42.9% | 1,214 | +21.4% | 0.00% | – |
Q2 2020 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $7,000 | -36.4% | 1,000 | -9.0% | 0.00% | – |
Q4 2019 | $11,000 | -8.3% | 1,099 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | -25.0% | 1,099 | -19.6% | 0.00% | – |
Q2 2019 | $16,000 | +1500.0% | 1,367 | +1280.8% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 99 | -44.7% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 179 | +19.3% | 0.00% | – |
Q3 2018 | $2,000 | -99.9% | 150 | -99.9% | 0.00% | – |
Q2 2016 | $2,394,000 | +0.5% | 188,529 | +4.6% | 0.00% | – |
Q1 2016 | $2,381,000 | -64.0% | 180,274 | -58.1% | 0.00% | -100.0% |
Q4 2015 | $6,610,000 | +233.8% | 429,774 | +169.2% | 0.00% | – |
Q3 2015 | $1,980,000 | -32.1% | 159,651 | -25.1% | 0.00% | – |
Q2 2015 | $2,914,000 | -81.0% | 213,043 | -83.4% | 0.00% | -100.0% |
Q1 2015 | $15,376,000 | -19.1% | 1,285,574 | -13.6% | 0.00% | 0.0% |
Q4 2014 | $18,995,000 | +3.6% | 1,487,489 | +8.8% | 0.00% | 0.0% |
Q3 2014 | $18,334,000 | -38.6% | 1,366,739 | -26.5% | 0.00% | -50.0% |
Q2 2014 | $29,859,000 | +58.3% | 1,860,339 | +77.8% | 0.00% | +33.3% |
Q1 2014 | $18,868,000 | +275.5% | 1,046,500 | +222.0% | 0.00% | +200.0% |
Q4 2013 | $5,025,000 | +4.0% | 325,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $4,833,000 | -6.6% | 325,000 | -18.8% | 0.00% | 0.0% |
Q2 2013 | $5,176,000 | – | 400,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |